Replies to post #102212 on Biotech Values

[go seek]

MNTA Lovenox Profits
given continued sole generic status for MNTA

according to my calculations... assuming scenario #msg-53629665

$75 -$100M profit in the first year of sales
or $1.66 - $2.22 earnings per share of MNTA in the first year

and $180M+ profit in the 2nd and subsequent years of sales... or $4 earnings per share of MNTA

MNTA has 45M shares outstanding